Clinical Trial Update: Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients? [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether radioiodine ablation is needed for low-risk differentiated thyroid cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Low Risk Differentiated Thyroid Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING